TP53 and cancer: For example, CAF-derived EVs were shown to transfer lipids and proteins to cancer cells to support tumour growth [17], including gain-of-function p53 [30], and pleiotropically modulate cancer cell metabolism [27] in prostate and pancreatic cancer, respectively.